Literature DB >> 15933569

Adenovirus infections in the immunocompromised host.

Leonard R Krilov1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15933569     DOI： 10.1097/01.inf.0000165306.95815.68

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

1.  Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.

Authors:  Artur Yakimovich; Heidi Gumpert; Christoph J Burckhardt; Verena A Lütschg; Andreas Jurgeit; Ivo F Sbalzarini; Urs F Greber
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

Review 2.  Novel viral vectored vaccines for the prevention of influenza.

Authors:  Teresa Lambe
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

3.  Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells.

Authors:  Verena Lütschg; Karin Boucke; Silvio Hemmi; Urs F Greber
Journal:  Nat Commun       Date:  2011-07-12       Impact factor: 14.919

4.  The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.

Authors:  Fanny Georgi; Vardan Andriasyan; Robert Witte; Luca Murer; Silvio Hemmi; Lisa Yu; Melanie Grove; Nicole Meili; Fabien Kuttler; Artur Yakimovich; Gerardo Turcatti; Urs F Greber
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

5.  Severe necrotizing adenovirus tubulointerstitial nephritis in a kidney transplant recipient.

Authors:  Ravi Parasuraman; Ping L Zhang; Dilip Samarapungavan; Leslie Rocher; Alan Koffron
Journal:  Case Rep Transplant       Date:  2013-08-28

Review 6.  Recombinant vectors as influenza vaccines.

Authors:  Sarah A Kopecky-Bromberg; Peter Palese
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.